tiprankstipranks

Top UK Pharma & Biotech Shares

Compare UK pharmaceutical companies and biotech shares. See a comparison of key indicators, including pharma stock price targets and analyst recommendations.
Compare up to 10 stocks or ETFs

Comparison Results

Name
Price
Price Change
Volume
Market Cap
Analyst Price Target
Analyst Consensus
Smart Score
Article
Follow
GB:AZN
AstraZeneca
12017.00p
9p
(0.07%)
248.10K£174.68B
11,933.44p
(-0.70% Downside)
14 Buy
4 Hold
1 Sell
Moderate Buy
GB:GSK
GlaxoSmithKline
1654.50p
14p
(0.85%)
309.48K£68.04B
1,908.10p
(15.33% Upside)
8 Buy
3 Hold
2 Sell
Moderate Buy
GB:HIK
Hikma Pharmaceuticals
1917.00p
77p
(4.18%)
67.23K£4.04B
2,120.83p
(10.63% Upside)
1 Buy
5 Hold
0 Sell
Hold
GB:HCM
HUTCHMED (China) Limited
304.00p
8p
(2.7%)
204.83K£2.53B
357.53p
(17.61% Upside)
2 Buy
0 Hold
0 Sell
Moderate Buy
GB:DPH
DPH

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
GB:AZN
AstraZeneca
12,026.00
486.73
4.22%
GB:GSK
GlaxoSmithKline
1,640.50
259.57
18.80%
GB:HIK
Hikma Pharmaceuticals
1,854.00
133.17
7.74%
GB:HCM
HUTCHMED (China) Limited
304.00
61.00
25.10%
GB:DPH
3,866.00
146.00
3.92%
Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Pharma & Biotech Stocks Latest News

Currently, no data available
Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Pharma & Biotech Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
Hikma Pharmaceuticals
Hold
Reiterated
GlaxoSmithKline
Sell
Reiterated
HUTCHMED (China) Limited
Buy
Initiated
Hikma Pharmaceuticals
Hold
Reiterated

Most Recent Earnings of Pharma & Biotech Stocks

Name
Report Date
Time Of Day
Period Ending
Forecast / EPS
Last Year's EPS
AstraZeneca
Apr 25, 2024
Mar 01, 2024
153.34 / 165.30
154.065
GlaxoSmithKline
Jan 31, 2024
Dec 01, 2023
29.00 / 28.90
25.8
Hikma Pharmaceuticals
Feb 22, 2024
Dec 01, 2023
- / 21.40
88.7
HUTCHMED (China) Limited
Feb 28, 2024
Dec 01, 2023
-17.27 / -11.19
-18.471
DPH
- / -

Pharma & Biotech Stocks - FAQ

Which Pharma & Biotech stocks have a "Strong Buy" analyst rating?
These Pharma & Biotech stocks currently have a "Strong Buy" analyst rating consensus:
None of the selected stocks have a “Strong Buy” analyst rating consensus.
    Are Pharma & Biotech stocks overpriced?
    AstraZeneca's stock price is currently 12,017.00p, and its average 12-month price target is 11,933.44p.
      GlaxoSmithKline's stock price is currently 1,654.50p, and its average 12-month price target is 1,908.10p.
        Hikma Pharmaceuticals's stock price is currently 1,917.00p, and its average 12-month price target is 2,120.83p.
          HUTCHMED (China) Limited's stock price is currently 304.00p, and its average 12-month price target is 357.53p.
            's stock price is currently N/A, and its average 12-month price target is N/A.
              Which Pharma & Biotech stocks pay dividends?
              AstraZeneca does not currently pay dividends.
                GlaxoSmithKline does not currently pay dividends.
                  Hikma Pharmaceuticals does not currently pay dividends.
                    HUTCHMED (China) Limited does not currently pay dividends.
                      does not currently pay dividends.

                        Latest News​

                        Vince CondarcuriAbbVie (NYSE:ABBV) Sinks as Humira Drug Sees Increased Competition
                        Vince CondarcuriBiden Administration Pauses Planned Ban of Menthol Cigarettes
                        Amit SinghStock Market News Today, 04/26/24 – Indices Rise; Inflation Data Heats Up
                        Steve AndersonIs Bob Bakish on Borrowed Time at Paramount (NASDAQ:PARA)?
                        Devina LohiaCan Broadcom Stock (NASDAQ:AVGO) Join the $1 Trillion Club?
                        Steve AndersonChicken Supply Normalizes at Chipotle (NASDAQ:CMG), Shares Spark Up
                        Steve AndersonRoku (NASDAQ:ROKU) Craters amid Rising FAST Competiton
                        Steve AndersonMore Plane Trouble for Boeing (NYSE:BA)
                        Jordan SauerRoyal Caribbean Cruises (NYSE:RCL): Record Sales and Record Risk
                        Steve AndersonPetrobras (NYSE:PBR) Settles Dividend Struggle, Shares Surge
                        Steve AndersonPfizer (NYSE:PFE) Notches Up on New FDA Approval
                        Steve AndersonIMO Earnings: Imperial Oil Slips despite Decent Earnings
                        Jonathan MorganEarning Big in the Gaming World: Immutable Launches a Multi-Million Dollar Quest
                        Shrilekha PetheMedia Companies Battle for NBA Streaming Rights
                        Shrilekha PetheTesla (NASDAQ:TSLA) Faces NHTSA Probe Over Autopilot Recall

                        Pharma & Biotech Stock Events

                        Stock
                        Type
                        Date
                        GlaxoSmithKline
                        Earnings ReleaseMay 01, 2024
                        AstraZeneca
                        Earnings ReleaseJul 25, 2024
                        GlaxoSmithKline
                        Earnings ReleaseJul 31, 2024
                        HUTCHMED (China) Limited
                        Earnings ReleaseJul 31, 2024
                        Hikma Pharmaceuticals
                        Earnings ReleaseAug 08, 2024

                        Popular Stocks

                        Company
                        Price & Change
                        Follow
                        Nvidia
                        Apple
                        Microsoft